Canlyniadau Chwilio - Thumar, Jaykumar

Drug targets and predictive biomarkers in the management of metastatic melanoma gan Thumar, Jaykumar, Giesen, Eva, Kluger, Harriet M

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Vandetanib (ZD6474) in the Treatment of Medullary Thyroid Cancer gan Deshpande, Hari, Roman, Sanziana, Thumar, Jaykumar, Sosa, Julie Ann

Cael y testun llawn Cael y testun llawn Cael y testun llawn

MEK targeting in N-RAS mutated metastatic melanoma gan Thumar, Jaykumar, Shahbazian, David, Aziz, Saadia A, Jilaveanu, Lucia B, Kluger, Harriet M

Cael y testun llawn Cael y testun llawn Cael y testun llawn

A Phase 1b Expansion Study of TAS-102 With Oxaliplatin For Refractory Metastatic Colorectal Cancer gan Cecchini, Michael, Kortmansky, Jeremy S., Cui, Can, Wei, Wei, Thumar, Jaykumar Ranchobdhai, Uboha, Nataliya V., Hafez, Navid, Lacy, Jill, Fischbach, Neal A., Sabbath, Kert D., Gomez, Christina M., Sporn, Jonathan Reed, Stein, Stacey, Hochster, Howard S.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Phase IB/II Randomized Study of FOLFIRINOX Plus Pegylated Recombinant Human Hyaluronidase Versus FOLFIRINOX Alone in Patients With Metastatic Pancreatic Adenocarcinoma: SWOG S1313 gan Ramanathan, Ramesh K., McDonough, Shannon L., Philip, Philip A., Hingorani, Sunil R., Lacy, Jill, Kortmansky, Jeremy S., Thumar, Jaykumar, Chiorean, E. Gabriela, Shields, Anthony F., Behl, Deepti, Mehan, Paul T., Gaur, Rakesh, Seery, Tara, Guthrie, Katherine A., Hochster, Howard S.

Cael y testun llawn Cael y testun llawn Cael y testun llawn